Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -10.56% is 81% above its 5-year average of -57.01%, near the high end of its 5-year range (-150.93%–-10.56%).
As of the fiscal period ended Tuesday, June 30, 2026. 34.40% above its 12-month average of -16.10%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -10.56%.
RETURN ON EQUITY (ROE)
-10.56%
RETURN ON EQUITY (ROE) AVG TTM
-16.10%
RETURN ON EQUITY (ROE) AVG 3Y
-32.57%
RETURN ON EQUITY (ROE) AVG 5Y
-57.01%
RETURN ON EQUITY (ROE) AVG 10Y
-75.25%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+34.40%
CURRENT VS 3Y AVG
+67.58%
CURRENT VS 5Y AVG
+81.48%
CURRENT VS 10Y AVG
+85.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 92 covered companies
CURRENT VS SECTOR MEDIAN
-192.31%
vs the sector median at left
Natera, Inc.
Market Cap
$58.64B
Return on Equity (ROE)
-10.56%
TTM Avg
-16.10%
3Y Avg
-32.57%
5Y Avg
-57.01%
Market Cap
$60.25B
Return on Equity (ROE)
86.03%
TTM Avg
168.34%
3Y Avg
-32.99%
5Y Avg
148.52%
Market Cap
$63.17B
Return on Equity (ROE)
14.71%
TTM Avg
10.21%
3Y Avg
8.16%
5Y Avg
6.40%
Market Cap
$53.70B
Return on Equity (ROE)
N/A
TTM Avg
-57.79%
3Y Avg
-38.31%
5Y Avg
2.19%
Market Cap
$49.07B
Return on Equity (ROE)
9.46%
TTM Avg
26.07%
3Y Avg
24.86%
5Y Avg
23.86%
Market Cap
$48.68B
Return on Equity (ROE)
3.85%
TTM Avg
6.60%
3Y Avg
6.50%
5Y Avg
6.42%
Market Cap
$47.49B
Return on Equity (ROE)
19.56%
TTM Avg
20.59%
3Y Avg
21.51%
5Y Avg
20.54%
Market Cap
$46.78B
Return on Equity (ROE)
6.65%
TTM Avg
7.05%
3Y Avg
11.93%
5Y Avg
15.09%
Market Cap
$45.97B
Return on Equity (ROE)
9.10%
TTM Avg
-6.34%
3Y Avg
-12.86%
5Y Avg
-14.53%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Natera, Inc. (NTRA) | $58.64B | -10.56% | -16.10% | -32.57% | -57.01% |
| Cencora, Inc. (COR)vs › | $60.25B | 86.03% | 168.34% | -32.99% | 148.52% |
| Boston Scientific Corporation (BSX)vs › | $63.17B | 14.71% | 10.21% | 8.16% | 6.40% |
| Cardinal Health, Inc. (CAH)vs › | $53.70B | N/A | -57.79% | -38.31% | 2.19% |
| Edwards Lifesciences Corporation (EW)vs › | $49.07B | 9.46% | 26.07% | 24.86% | 23.86% |
| Becton, Dickinson and Company (BDX)vs › | $48.68B | 3.85% | 6.60% | 6.50% | 6.42% |
| Agilent Technologies, Inc. (A)vs › | $47.49B | 19.56% | 20.59% | 21.51% | 20.54% |
| Humana Inc. (HUM)vs › | $46.78B | 6.65% | 7.05% | 11.93% | 15.09% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.97B | 9.10% | -6.34% | -12.86% | -14.53% |
| Cigna Corporation (CI)vs › | $71.56B | 15.05% | 11.32% | 12.19% | 12.83% |
ROE
-10.6%
ROA
-7.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -10.56% |
| 2026-03-31 | -12.76% |
| 2025-12-31 | -12.16% |
| 2025-09-30 | -24.69% |
| 2025-06-30 | -20.32% |
| 2025-03-31 | -15.31% |
| 2024-12-31 | -15.93% |
| 2024-09-30 | -24.44% |
| 2024-06-30 | -34.92% |
| 2024-03-31 | -46.02% |
| 2023-12-31 | -56.81% |
| 2023-09-30 | -63.64% |
| 2023-06-30 | -85.85% |
| 2023-03-31 | -83.95% |
| 2022-12-31 | -77.62% |
| 2022-09-30 | -150.93% |
| 2022-06-30 | -129.47% |
| 2022-03-31 | -100.76% |
| 2021-12-31 | -72.20% |
| 2021-09-30 | -53.70% |
| 2021-06-30 | -105.18% |
| 2021-03-31 | -69.33% |
| 2020-12-31 | -47.25% |
| 2020-09-30 | -35.17% |
| 2020-06-30 | -50.39% |
| 2020-03-31 | -48.70% |
| 2019-12-31 | -44.79% |
| 2019-09-30 | -143.44% |
| 2019-06-30 | -137.47% |
| 2018-12-31 | -398.46% |
| 2018-09-30 | -250.68% |
| 2017-12-31 | -536.31% |
| 2017-09-30 | -426.45% |
| 2017-06-30 | -250.68% |
| 2017-03-31 | -167.01% |
| 2016-12-31 | -89.94% |
| 2016-09-30 | -57.60% |
| 2016-06-30 | -44.22% |
| 2016-03-31 | -37.97% |
| 2015-12-31 | -38.03% |
| 2015-09-30 | -22.35% |
| 2015-03-31 | -9.16% |
| 2014-09-30 | -97.29% |
